[1] Trevisani F, Cantarini MC, Wands JR, et al. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 2008; 29 (7): 1299-1305.
[2] McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19 (1): 3-23.
[3] Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28:1241– 46.
[4] Midorikawa Y, Yamamoto S, Tsuji S, et al. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 2009;49:513–22.
[5] Yamamoto M, Takasaki K, Otsubo T, et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004; 239:395–9.
[6] Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for earlystage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30:37-47
[7] Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011;9:161-167
[8] Takayasu K, Arii S, Sakamoto M, et al. Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3cm[J]. Liver International, 2013, 33(5):762-770.
[9] Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005; 42 (1): 27-34.
[10]Min JH, Kim YK, Kang TW, et al. Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging. Eur Radiol, 2018, 28(8): 3335-3346.
[10] Silva M A, Hegab B, Hyde C, et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis[J]. Gut, 2008, 57 (11): 1592-1596
[11] Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28:1241–46.
[12] Midorikawa Y, Yamamoto S, Tsuji S, et al. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 2009; 49: 513–22.
[13] Yamamoto M, Takasaki K, Otsubo T, et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg 2004; 239: 395–9.
[14] Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: Extracting more information from medical images using advanced feature analysis[J]. European journal of cancer (Oxford, England: 1990), 2012, 48 (4): 441-446.
[15] Shen ZW, Cao Z, You KZ, et al. Quantification of choline concentration following liver cell apoptosis using 1H magnetic resonance spectroscopy. World J Gastroenterol. 2012; 18: 1130–1136.
[16] Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57 (1): 69–76.
[17] Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003;3(6):573–588.
[18] Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 2011;21(10):2056–2066.
[19] Ojima H , Masugi Y , Tsujikawa H , et al. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions[J]. Cancer Science, 2016, 107(4):543-550.
[20] International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49(2):658–664.
[21] Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 1990;65(9):1994–2000.
[22] Gurusamy K. Trace element concentration in primary liver cancers—a systematic review. Biol Trace Elem Res 2007;118(3):191–206.
[23] Zwanenburg, A., Leger, S., Vallières, M., and Löck, S. (2016). Image biomarker standardisation initiative - feature definitions. In eprint arXiv:1612.07003 [cs.CV]
[24] Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 2001;438(6):574–580.
[25] Malaguarnera G, Giordano M, Paladinal I, et al. Serum markers of hepatocellular carcinoma. Dig Dis Sci, 2010, 55: 2744-2755.
[26] Johnson, Philip J. The Role of Serum Alpha-Fetoprotein estimation in the Diagnosis and Management of Hepatocellular Carcinoma[J]. Clinics in Liver Disease, 2001, 5(1):145-159.
[27] Kobayashi M, Ikeda K, Hosaka T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 2006; 106: 636-47.